EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Specificity of DNA ADP-Ribosylation Reversal by NADARs

Bara Cihlova iD, Yang Lu, Andreja Mikoč, Marion Schuller iD, Ivan Ahel iD

Toxins · 2024

DOI: 10.3390/toxins16050208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Bara Cihlova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK. Hauptthemen laut MEDLINE: ADP-Ribosylation, Escherichia coli. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oxford University Challenge Seed Fund, Biotechnology and Biological Sciences Research Council, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent discoveries establish DNA and RNA as bona fide substrates for ADP-ribosylation. NADAR (“NAD- and ADP-ribose”-associated) enzymes reverse guanine ADP-ribosylation and serve as antitoxins in the DarT-NADAR operon. Although NADARs are widespread across prokaryotes, eukaryotes, and viruses, their specificity and broader physiological roles remain poorly understood. Using phylogenetic and biochemical analyses, we further explore de-ADP-ribosylation activity and antitoxin functions of NADAR domains. We demonstrate that different subfamilies of NADAR proteins from representative E. coli strains and an E. coli-infecting phage retain biochemical activity while displaying specificity in providing protection from toxic guanine ADP-ribosylation in cells. Furthermore, we identify a myxobacterial enzyme within the YbiA subfamily that functions as an antitoxin for its associated DarT-unrelated ART toxin, which we termed YarT, thus presenting a hitherto uncharacterised ART-YbiA toxin–antitoxin pair. Our studies contribute to the burgeoning field of DNA ADP-ribosylation, supporting its physiological relevance within and beyond bacterial toxin–antitoxin systems. Notably, the specificity and confinement of NADARs to non-mammals infer their potential as highly specific targets for antimicrobial drugs with minimal off-target effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADP-RibosylationEscherichia coliEscherichia coli ProteinsBacterial ToxinsAdenosine Diphosphate RibosePhylogenyToxin-Antitoxin SystemsDNA, BacterialDNA

Stichwörter der Autor:innen

ADP-ribosylationDNA damageDNA modificationDarTGPARPYbiAtoxin–antitoxin system

Substanzen

Escherichia coli ProteinsBacterial ToxinsAdenosine Diphosphate RiboseDNA, BacterialDNA

Autor:innen und Institutionen

  • Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
  • Division of Molecular Biology, Ruđer Bošković Institute, 10000 Zagreb, Croatia.

ORCID-Profile: Bara Cihlova, Marion Schuller, Ivan Ahel

Förderung

  • Oxford University Challenge Seed Fund
  • Biotechnology and Biological Sciences Research Council
  • Cancer Research UK
  • Ovarian Cancer Research Alliance
  • Wellcome Trust
  • Cancer Research United Kingdom
  • Goodger and Schorstein Scholarships Trust Fund

Zitieren

APA

Cihlova, B., Lu, Y., Mikoč, A., Schuller, M., & Ahel, I. (2024). Specificity of DNA ADP-Ribosylation Reversal by NADARs. Toxins. https://doi.org/10.3390/toxins16050208

Vancouver

Cihlova B, Lu Y, Mikoč A, Schuller M, Ahel I. Specificity of DNA ADP-Ribosylation Reversal by NADARs. Toxins. 2024. doi:10.3390/toxins16050208

BibTeX
@article{Cihlova2024,
  author = {Cihlova, Bara and Lu, Yang and Mikoč, Andreja and Schuller, Marion and Ahel, Ivan},
  title = {Specificity of DNA ADP-Ribosylation Reversal by NADARs},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16050208}
}
Kostenlos starten →